Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD



Rating:

Share or cite this content

Citations should be made in the following way:
M. Goldklang (New York, United States of America), K. Law (New York, United States of America), A. Gerber (New York, United States of America), J. Olsen (New York, United States of America), C. Henry (New York, United States of America), G. Wagener (New York, United States of America), J. D'Armiento (New York, United States of America). Increased Exacerbations of Chronic Obstructive Pulmonary Disease in Alpha-1 Antitrypsin Carriers. 3824

Member's Comments

No comment yet.

Related content which might interest you: Chronic Obstructive Pulmonary Disease Exacerbations Source: Eur Respir Rev 2009; 18: 305 Year: 2009 Risk Factor for Chronic Obstructive Pulmonary Disease in Never-Smoker Patients with Non-Cystic Fibrosis Bronchiectasis Source: International Congress 2019 – Bronchiectasis Year: 2019 Evaluation of Co-morbidities among Different Chronic Obstructive Pulmonary Disease Phenotypes Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018 Low Level of  Airway Mucin 2 Predict Severe Exacerbations in Patients with Severe Chronic Obstructive Pulmonary Disease Source: International Congress 2017 – COPD biomarkers Year: 2017 Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease Source: Virtual Congress 2020 - Pre-reading material Year: 2020 Determinants of Airflow Limitation in Chronic Obstructive Pulmonary Disease Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair Year: 2020 The Effects Of Bronchiectasis Severity On Outcomes Of Chronic Obstructive Pulmonary Disease Exacerbation Source: International Congress 2017 – Imaging markers for COPD and asthma Year: 2017 Upper Respiratory Symptoms in Patients with Chronic Obstructive Pulmonary Disease Source: Virtual Congress 2020 – Clinical characteristics and diagnostic tools for phenotyping asthma and COPD Year: 2020 Update on Limb Muscle Dysfunction in Chronic Obstructive Pulmonary Disease Source: Guideline 2014 Year: 2014 From the Cradle to the Grave - The Early-Life Origins of Chronic Obstructive Pulmonary Disease Source: Virtual Congress 2020 - Pre-reading material Year: 2020 Pathogenic bacteria for exacerbation of Chronic Obstructive Pulmonary Disease Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018 The Impact of Multimorbidity on Hospitalizations in Patients with Chronic Obstructive Pulmonary Disease (COPD): a Population-Based Study Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019 A Comparison of Pulmonary Rehabilitation Outcomes in Interstitial Lung Disease and Chronic Obstructive Pulmonary Disease Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases Year: 2019 Skeletal Muscle Dysfunction in Chronic Obstructive Pulmonary Disease Source: Guideline 1999 Year: 1999 Association of Metabolic Syndrome with the severity of Chronic Obstructive Pulmonary Disease Source: Virtual Congress 2020 – Clinical data and COPD management Year: 2020 Chronic Obstructive Pulmonary Disease: A Forgotten Killer Source: Eur Respir J 2009; 33: 456 Year: 2009 Sexuality in Chronic Obstructive Pulmonary Disease (SEXY COPD) Source: Virtual Congress 2020 – Comprehensive care and pulmonary rehabilitation for chronic respiratory diseases Year: 2020 Nutritional Disorders of Patients with Chronic Obstructive Pulmonary Disease Source: International Congress 2019 – COPD and other specific entities in intensive care unit medicine Year: 2019 Impact of Pulmonary Hypertension on the Response to Pulmonary Rehabilitation in Obstructive Lung Disease Source: International Congress 2019 – The future of pulmonary rehabilitation discussed today Year: 2019